Skip to main content
HCSG logo

HCSG · Healthcare Services Group Inc · Metrics

Track HCSG — free
Market Cap
$1.69B
Shares
67.43M
Volume · Nov 18 618.8K Avg daily vol (3M) 692.36K

HCSG metrics

98 of 125 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$25.10
Market cap
$1.69B

Price action

23 metrics
Price change (1W)
-0.4%
Price change (30D)
+18.9%
Price change (3M)
+9.5%
Price change (6M)
+20.6%
Price change (YTD)
+31.3%
Price change (1Y)
+46.0%
Trailing year
Price change (5Y)
+32.9%
52-week high
$26.54
52-week low
$17.19
Change from 52-week high
-5.4%
Change from 52-week low
+46.0%
Annualized volatility
42.4%
Annualized volatility (3M)
38.9%
Implied volatility (30D)
42.9%
IV rank (1Y)
—
IV percentile (1Y)
—
Beta
0.7
RSI (14D)
58.5
Price vs SMA 50
+10.5%
Price vs SMA 200
+15.1%
Avg volume (3M)
692,362
Relative volume
0.9
Average dollar volume
$15.65M

Company

3 metrics
Sector
Healthcare
Industry
Medical Care Facilities
Shares outstanding
67.43M

Valuation

12 metrics
P / E (TTM)
17.0
Trailing earnings · reciprocal yield 5.9%
PEG ratio
—
EV / revenue
0.8×
reciprocal yield 123.4%
EV / EBITDA
—
EV / EBIT
—
P / sales
0.9×
reciprocal yield 111.1%
P / book
3.2
reciprocal yield 31.4%
FCF yield
6.3%
TTM · current market cap
Buyback yield
4.5%
P / FCF
15.9
reciprocal yield 6.3%
P / operating cash flow
15.0
reciprocal yield 6.7%
Earnings yield
6.2%

Historical valuation

8 metrics
P / E historical average (3Y)
20.7×
reciprocal yield 4.8%
P / E historical average (5Y)
27.1×
reciprocal yield 3.7%
EV / revenue historical average (3Y)
0.6×
reciprocal yield 181.1%
EV / revenue historical average (5Y)
0.6×
reciprocal yield 176.9%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
4.5%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
0
Last ex-dividend
2022-11-17

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-10-21

Profitability

9 metrics
Gross margin
16.1%
Operating margin
—
Trailing 12 months
Net margin
5.6%
Gross profit (TTM)
$303.09M
Operating profit (TTM)
—
Net income (TTM)
$104.88M
Trailing 12 months
Diluted EPS (TTM)
$1.48
FCF margin
5.7%
Effective tax rate
18.0%

Per share

11 metrics
Revenue per diluted share (TTM)
$26.64
Gross profit per diluted share (TTM)
$4.30
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
$1.48
Operating cash flow per diluted share (TTM)
$1.60
Free cash flow per diluted share (TTM)
$1.51
Capital expenditures per diluted share (TTM)
$0.09
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
$0.17
Book value per share
$7.33

Growth

11 metrics
Revenue growth YoY
+3.3%
Year over year
Net income growth YoY
-42.1%
Revenue (TTM)
$1.88B
Trailing 12 months
EPS growth YoY
-39.0%
Shares change YoY
-4.9%
Year over year · fewer shares
Revenue CAGR (3Y)
+2.8%
Revenue CAGR (5Y)
+0.9%
EPS CAGR (3Y)
+20.8%
EPS CAGR (5Y)
-9.3%
FCF CAGR (3Y)
—
FCF CAGR (5Y)
-8.2%

Quality

14 metrics
Return on equity
19.7%
Return on assets
12.3%
Debt / equity
0.0
Current ratio
2.8
EBITDA (TTM)
—
Free cash flow (TTM)
$106.68M
Quick ratio
2.7
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$168.82M
Latest balance sheet
Cash & equivalents
$134.60M
Total assets
$850.40M
Total debt
$0

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$113.16M
Capital expenditures (TTM)
$6.48M
R&D (TTM)
—
SG&A (TTM)
$189.23M
Stock compensation (TTM)
$11.65M
R&D / revenue
—
Stock compensation / revenue
0.6%

Ownership (13F)

9 metrics
13F filers
278
13F filer change QoQ
+1
Institutional ownership
101.6%
Conviction holders (share of 13F filers)
0.4%
Crowding (high-turnover and private-fund holders)
27.9%
Private-fund adviser ownership
26.5%
Active holders' share change QoQ
-3.7%
Holder tenure
15.4
Price vs estimated holder cost
+12.1%

Ownership (registered funds)

1 metrics
Index-fund ownership
31.7%

Short interest

3 metrics
Short interest
3.7%
Latest settlement · 2.7 days to cover
Days to cover
2.7d
Short-squeeze score
59 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$457,981
Insider-sentiment score
36 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 731012 CUSIP 421906108 13F (30d) 278 filings 261 filers Visit website Investor relations